1. Home
  2. GKOS vs SNDK Comparison

GKOS vs SNDK Comparison

Compare GKOS & SNDK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • SNDK
  • Stock Information
  • Founded
  • GKOS 1998
  • SNDK 2024
  • Country
  • GKOS United States
  • SNDK United States
  • Employees
  • GKOS N/A
  • SNDK N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • SNDK
  • Sector
  • GKOS Health Care
  • SNDK
  • Exchange
  • GKOS Nasdaq
  • SNDK NYSE
  • Market Cap
  • GKOS 5.5B
  • SNDK 4.9B
  • IPO Year
  • GKOS 2015
  • SNDK N/A
  • Fundamental
  • Price
  • GKOS $100.14
  • SNDK $46.58
  • Analyst Decision
  • GKOS Strong Buy
  • SNDK Buy
  • Analyst Count
  • GKOS 13
  • SNDK 9
  • Target Price
  • GKOS $135.15
  • SNDK $59.22
  • AVG Volume (30 Days)
  • GKOS 909.8K
  • SNDK 3.4M
  • Earning Date
  • GKOS 07-30-2025
  • SNDK 08-07-2025
  • Dividend Yield
  • GKOS N/A
  • SNDK N/A
  • EPS Growth
  • GKOS N/A
  • SNDK N/A
  • EPS
  • GKOS N/A
  • SNDK N/A
  • Revenue
  • GKOS $404,523,000.00
  • SNDK $7,214,000,000.00
  • Revenue This Year
  • GKOS $27.88
  • SNDK $10.81
  • Revenue Next Year
  • GKOS $27.60
  • SNDK $13.96
  • P/E Ratio
  • GKOS N/A
  • SNDK N/A
  • Revenue Growth
  • GKOS 23.92
  • SNDK 18.53
  • 52 Week Low
  • GKOS $77.10
  • SNDK $27.89
  • 52 Week High
  • GKOS $163.71
  • SNDK $58.36
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 58.49
  • SNDK N/A
  • Support Level
  • GKOS $97.54
  • SNDK N/A
  • Resistance Level
  • GKOS $102.82
  • SNDK N/A
  • Average True Range (ATR)
  • GKOS 3.51
  • SNDK 0.00
  • MACD
  • GKOS 0.67
  • SNDK 0.00
  • Stochastic Oscillator
  • GKOS 77.52
  • SNDK 0.00

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About SNDK SANDISK CORP

SanDisk Corp is one of the five largest suppliers of NAND flash memory semiconductors globally. Sandisk is vertically integrated, producing substantially all of its flash chips at manufacturing sites across Japan via a joint-venture framework with Kioxia. Sandisk then repackages majority of its chips into SSDs for consumer electronics, external storage, or cloud storage. Sandisk was formerly a piece of Western Digital for nine years (after being acquired in 2016) and was spun off as an independent company in 2025.

Share on Social Networks: